Kenneth A. Berlin
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Ken Berlin served as Advaxis President and Chief Executive Officer, Interim Chief Financial Officer and was a member of the Board of Directors prior to the merger with Ayala Pharmaceuticals. Before joining Advaxis, Ken held the position of President and Chief Executive Officer of Rosetta Genomics. He was Worldwide General Manager at cellular and molecular cancer diagnostics developer Veridex, LLC, a Johnson & Johnson company. At Veridex, he grew the organization to over 100 employees, launched three cancer diagnostic products, led the acquisition of its cellular diagnostics partner and delivered significant growth in sales as Veridex transitioned from an R&D entity to a commercial provider of oncology diagnostic products and services. Ken began his Johnson & Johnson tenure as corporate counsel, became Vice President, Licensing and New Business Development in the pharmaceuticals group, followed by Worldwide Vice President, Franchise Development, for Ortho-Clinical Diagnostics. Ken holds an AB degree from Princeton University and a JD from the University of California Los Angeles School of Law.